Lukas Klameth

475 citations
13 papers · 397 · h-index 11

Impact in

  • Oncology top 10%
    • Cancer Cells and Metastasis
    • Lung Cancer Research Studies
    • Peptidase Inhibition and Analysis
    • Drug Transport and Resistance Mechanisms
    • Cancer Genomics and Diagnostics

Papers in

    • Lung Cancer Research Studies 6
    • Cancer Cells and Metastasis 5
    • Drug Transport and Resistance Mechanisms 2
    • Peptidase Inhibition and Analysis 1
    • Neuroendocrine Tumor Research Advances 4

Lukas Klameth

13 papers receiving 391 citations

Peers

Lukas Klameth
Comparison fields: 5 of 71
  • Oncology 255
  • Cancer Research 119
  • Molecular Biology 151
  • Biotechnology 19
  • Pulmonary and Respiratory Medicine 63
Replace Luca Ricotti with:
Luca Ricotti Italy
Nicole D. Facompre United States
Ewoud N. Speksnijder Netherlands
Ramón González Manzano Spain
Mingzhu Huang China
Linara Gabitova United States
Kari Trumpi Netherlands
Yanping Zhong China
Kazuto Nishio Japan
Kaushlendra Tripathi United States
Lukas Klameth relative to Luca Ricotti Italy Luca Ricotti's profile →
Citations per field
00.5×8.8×
Luca Ricotti · 1×
Citations per year

Countries citing papers authored by Lukas Klameth

Since Specialization
Citations

This map shows the geographic impact of Lukas Klameth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Klameth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Klameth more than expected).

Fields of papers citing papers by Lukas Klameth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Klameth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Klameth. The network helps show where Lukas Klameth may publish in the future.

Co-authors

The 23 scholars most cited alongside Lukas Klameth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lukas Klameth Line = papers co-authored together Lukas Klameth links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 201582
2 201771
3 201360
4 201651
5 201422
6 201921
7 201520
8 201418
9 201818
10 201914
11 201410
12 20176
13 20234

About Lukas Klameth

Lukas Klameth is a scholar working on Oncology, Epidemiology, Molecular Biology, Immunology and Cancer Research, having authored 13 papers that have together received 397 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Cancer Cells and Metastasis (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Cancer therapeutics and mechanisms (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Peptidase Inhibition and Analysis (1 paper), Alzheimer's disease research and treatments (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (255 citations), Cancer Research (119 citations), Molecular Biology (151 citations), Biotechnology (19 citations) and Pulmonary and Respiratory Medicine (63 citations). Lukas Klameth has collaborated with scholars based in Austria, Belgium and Russia. Frequent co-authors include Gerhard Hamilton, Barbara H. Rath, Robert Zeillinger, Maximilian J. Hochmair, Theresia Thalhammer, Ernst Ulsperger, Walter Jäger, Erika Bajna, Martin Svoboda and Doris Moser. Their work appears in journals such as Cancers, Scientific Reports, Investigational New Drugs, Cancer Letters and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact